MELISSA MORAN: Open Payments
NPI 1427574839 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 32 payments from 9 companies in 2025. Trend: 2023 $239 · 2024 $470 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $141 |
| Tandem Diabetes Care, Inc. | 6 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $113 |
| Medtronic, Inc. | 1 | $109 |
| Lilly USA, LLC | 6 | $104 |
| Sequel Med Tech, LLC | 4 | $85 |
| Abbott Laboratories | 4 | $77 |
| Ascendis Pharma Endocrinology Inc | 1 | $77 |
| Novo Nordisk Inc | 3 | $65 |
Products named: Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, JARDIANCE, MINIMED 780G, MOUNJARO, TWIIST, FREESTYLE LIBRE 3, Yorvipath.
Industry payments across PA — which companies pay providers there.
